Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF Combined With IL-11 for Hematopoietic Reconstitution After Auto-HSCT
NCT07362810Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of oprelvekin in multiple myeloma (MM), lymphoma, sponsored by Fudan University. Started Jan 2026; status: recruiting.
02
Drugs
oprelvekin
03
Conditions
multiple myeloma (MM)lymphoma
Beyond the preview
Go deeper on NCT07362810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07362810.